| # | Drug | Count |
|---|---|---|
| 0 | METOPROLOL | 40 |
| 1 | METOPROLOL TARTRATE | 40 |
| 2 | VENLAFAXINE HYDROCHLORIDE | 40 |
| 3 | METOPROLOL TARTRATE INJECTION | 38 |
| 4 | METHYLDOPA | 36 |
| 5 | VENLAFAXINE | 32 |
| 6 | SPIRONOLACTONE | 29 |
| 7 | PORACTANT ALFA | 28 |
| 8 | AMPICILLIN | 24 |
| 9 | AMPICILLIN INJECTION | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, LEVOMEFOLATE CALCIUM, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, MAGNESIUM OXIDE AND DOCONEXENT | 1 | 0.0476 |
| 1 | PORACTANT ALFA | 28 | 0.0380 |
| 2 | BERACTANT | 5 | 0.0136 |
| 3 | ARGININE HYDROCHLORIDE | 1 | 0.0097 |
| 4 | ATRACURIUM BESYLATE | 6 | 0.0085 |
| 5 | METHYLDOPA | 36 | 0.0073 |
| 6 | CHORIONIC GONADOTROPIN | 2 | 0.0036 |
| 7 | AMPICILLIN AND SULBACTAM | 3 | 0.0034 |
| 8 | AMPICILLIN INJECTION | 24 | 0.0032 |
| 9 | AMPICILLIN | 24 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 39 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 34 |
| 2 | Surfactant [EPC] | 33 |
| 3 | Aldosterone Antagonist [EPC] | 29 |
| 4 | Benzodiazepine [EPC] | 27 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 24 |
| 6 | Loop Diuretic [EPC] | 18 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 17 |
| 8 | Calcium Channel Blocker [EPC] | 16 |
| 9 | Opioid Agonist [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 33 | 0.0284 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 2 | 0.0024 |
| 2 | Oxytocic [EPC] | 2 | 0.0007 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 4 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 5 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Cannabinoid [EPC] | 2 | 0.0002 |
| 7 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 8 | Insulin [EPC] | 11 | 0.0002 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |